Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-10
Closed -$3.31K – 160
2022
Q4
$3.31K Hold
10
– – ﹤0.01% 389
2022
Q3
$3K Hold
10
– – ﹤0.01% 395
2022
Q2
$3K Hold
10
– – ﹤0.01% 341
2022
Q1
$2K Hold
10
– – ﹤0.01% 335
2021
Q4
$2K Hold
10
– – ﹤0.01% 352
2021
Q3
$2K Sell
10
-20
-67% -$4.35K ﹤0.01% 336
2021
Q2
$7K Hold
30
– – ﹤0.01% 297
2021
Q1
$7K Hold
30
– – ﹤0.01% 312
2020
Q4
$6K Buy
30
+10
+50% +$1.96K ﹤0.01% 300
2020
Q3
$3K Hold
20
– – ﹤0.01% 307
2020
Q2
$4K Hold
20
– – ﹤0.01% 364
2020
Q1
$4K Hold
20
– – ﹤0.01% 291
2019
Q4
$4K Buy
+20
New +$3.67K ﹤0.01% 290

Other funds holding CI

Leelyn Smith's CI Position: Q1 2023 in Review

Leelyn Smith sold out of Cigna (CI) in Q1 2023, closing a stake of 10 shares — an estimated $3.31K sold.

Leelyn Smith first reported a position in CI in Q4 2019 and held it in 13 quarters. The position peaked at $7K in Q2 2021. 1,485 funds tracked by Wall St. Rank hold CI as of Q1 2023.

  • Leelyn Smith reported no remaining Cigna position as of Q1 2023 after selling out during the quarter.
  • Leelyn Smith sold 10 Cigna shares in Q1 2023, an estimated $3.31K.
  • Leelyn Smith first reported a position in Cigna in Q4 2019 and held it in 13 quarters.
  • Leelyn Smith's Cigna position peaked at $7K in Q2 2021.
  • 1,485 funds tracked by Wall St. Rank held Cigna as of Q1 2023.

Based on Leelyn Smith's 13F filing for Q1 2023, filed 12 May 2023.